TLR4 and asthma: The filarial nematode-derived immunomodulator, ES-62 protects against development of asthma in both acute and chronic mouse models11,12 at least in part by suppressing FεcRI- and LPS/TLR4-mediated activation of mast cells and downregulation of type-2 inflammatory responses10–14.